4//SEC Filing
Chu Yu-Waye 4
Accession 0001209191-22-025159
CIK 0001434316other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 4:04 PM ET
Size
5.5 KB
Accession
0001209191-22-025159
Insider Transaction Report
Form 4
Chu Yu-Waye
Senior VP Clinical Development
Transactions
- Sale
Common Stock
2022-04-19$35.37/sh−4,062$143,673→ 151,033 total
Footnotes (2)
- [F1]Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 7,500 shares of Common Stock underlying RSUs granted to the reporting person on April 15, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]Represents the weighted average sale price of the shares sold from $35.10 to $35.50 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001854586
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 4:04 PM ET
- Size
- 5.5 KB